Cellectar Biosciences
CLRB
CLRB
20 hedge funds and large institutions have $2.14M invested in Cellectar Biosciences in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
85% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 13
Holders
20
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$50K | |
| 2 | +$40K | |
| 3 | +$30.6K | |
| 4 |
Renaissance Technologies
New York
|
+$3.5K |
Top Sellers
| 1 | -$50.4K | |
| 2 | -$39K | |
| 3 | -$31.1K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$28K |
| 5 |
CAM
Cozad Asset Management
Champaign,
Illinois
|
-$23K |